Shawn E. Stovall
Founder at Sontra Medical, Inc.
Profile
Shawn E.
Stovall is Chief Operating Officer of Palmett Pharmaceuticals, Inc. He is Founder of Reprogenesis, Inc. and Sontra Medical, Inc. Mr. Stovall received an undergraduate degree from Southern Methodist University.
Shawn E. Stovall active positions
| Companies | Position | Start |
|---|---|---|
| Sontra Medical, Inc. | Founder | 26/10/2009 |
Former positions of Shawn E. Stovall
| Companies | Position | End |
|---|---|---|
Enos Pharmaceuticals, Inc.
 Enos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Palmetto Pharmaceuticals LLC, Enos Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Lexington, MA. The company was founded by James R. McNab, Alexander M. Klibanov. | Chief Operating Officer | 07/07/2010 |
Reprogenesis, Inc.
 Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Founder | 06/11/2008 |
Training of Shawn E. Stovall
| Southern Methodist University | Undergraduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
Enos Pharmaceuticals, Inc.
Enos Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Palmetto Pharmaceuticals LLC, Enos Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in Lexington, MA. The company was founded by James R. McNab, Alexander M. Klibanov. | Health Technology |
Reprogenesis, Inc.
Reprogenesis, Inc. BiotechnologyHealth Technology Reprogenesis, Inc., located in Cambridge, Massachusetts developes tissue engineered therapies to treat unmet medical needs. The Company has proprietary technology utilizing the combination of cells and biomaterials to restore, repair or replace lost tissue or physiological function. The Company has a broad preclinical and clinical pipeline of products in the areas of urology, cardiovascular biology and plastic and reconstructive surgery. ChondrogelTM is its most advanced product | Health Technology |
| Sontra Medical, Inc. |
- Stock Market
- Insiders
- Shawn E. Stovall
